The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
Authors
Keywords
-
Journal
DALTON TRANSACTIONS
Volume 47, Issue 25, Pages 8268-8282
Publisher
Royal Society of Chemistry (RSC)
Online
2018-06-01
DOI
10.1039/c7dt04614f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Research progress in modern structure of platinum complexes
- (2017) Linkui Bai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models
- (2017) Simone Göschl et al. Metallomics
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Antiproliferative activity of a series of cisplatin-based Pt(iv)-acetylamido/carboxylato prodrugs
- (2016) Mauro Ravera et al. DALTON TRANSACTIONS
- Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches
- (2016) Igor V. Tetko et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways
- (2016) Penjai Thongnuanjan et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation
- (2016) Ekaterina Schreiber-Brynzak et al. Metallomics
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(iv)–acetamidato complex
- (2015) Giorgio Pelosi et al. CHEMICAL COMMUNICATIONS
- Microwave-assisted synthesis of the anticancer drug cisplatin, cis-[Pt(NH3)2Cl2]
- (2015) Emanuele Petruzzella et al. DALTON TRANSACTIONS
- Host–guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins
- (2015) Mauro Ravera et al. INORGANICA CHIMICA ACTA
- Application of microwave-assisted heating to the synthesis of Pt(II) complexes
- (2015) Elisabetta Gabano et al. INORGANICA CHIMICA ACTA
- Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs
- (2015) Mauro Ravera et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
- (2015) Karthic Chandran et al. Oncotarget
- Accurate prediction of 195Pt NMR chemical shifts for a series of Pt(ii) and Pt(iv) antitumor agents by a non-relativistic DFT computational protocol
- (2014) Athanassios C. Tsipis et al. DALTON TRANSACTIONS
- Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
- (2014) Elisabetta Gabano et al. DALTON TRANSACTIONS
- The potential role of HIF on tumour progression and dissemination
- (2014) Sandeep Unwith et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of hypoxia on human cancer cell line chemosensitivity
- (2013) Sara Strese et al. BMC CANCER
- Clofibrate Induces Heme Oxygenase 1 Expression through a PPARa-Independent Mechanism in Human Cancer Cells
- (2013) Shuai Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A map of the PPARα transcription regulatory network for primary human hepatocytes
- (2013) Patrick D. McMullen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
- (2013) Jennifer Adamski et al. PLoS One
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
- (2012) Jenny Z. Zhang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(iv) complexes
- (2012) Giuseppe Ermondi et al. DALTON TRANSACTIONS
- Activation of Peroxisome Proliferator-activated Receptor α (PPARα) Suppresses Hypoxia-inducible Factor-1α (HIF-1α) Signaling in Cancer Cells
- (2012) Jundong Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia modulation of peroxisome proliferator-activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy
- (2012) Renato Galzio et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- What do we know about the reduction of Pt(IV) pro-drugs?
- (2012) Ezequiel Wexselblatt et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- (2011) Ilaria Zanellato et al. ChemMedChem
- Preparation of cisplatin using microwave heating and continuous-flow processing as tools
- (2011) Elizabeth A. Pedrick et al. INORGANIC CHEMISTRY COMMUNICATIONS
- Protein and its function based on a subcellular localization
- (2011) Jana Ćmielová et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells
- (2011) G. Laurenti et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Valproic acid overcomes hypoxia-induced resistance to apoptosis
- (2011) ŠIMON CIPRO et al. ONCOLOGY REPORTS
- HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention
- (2011) Elena Monti et al. Current Molecular Pharmacology
- In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects
- (2010) Ilaria Zanellato et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs
- (2010) Alina Nemirovski et al. CHEMICAL COMMUNICATIONS
- Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes
- (2010) James A. Platts et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modeling
- (2010) Paola Gramatica et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
- (2009) F. Penna et al. CURRENT MEDICINAL CHEMISTRY
- The mechanism of action of platinum anticancer agents—what do we really know about it?
- (2009) Dan Gibson DALTON TRANSACTIONS
- Applications of heteronuclear NMR spectroscopy in biological and medicinal inorganic chemistry
- (2008) Luca Ronconi et al. COORDINATION CHEMISTRY REVIEWS
- [1H,15N] Heteronuclear Single Quantum Coherence NMR Study of the Mechanism of Aquation of Platinum(IV) Ammine Complexes
- (2008) Murray S. Davies et al. INORGANIC CHEMISTRY
- Calculation of lipophilicity for Pt(II) complexes: Experimental comparison of several methods
- (2008) Igor V. Tetko et al. JOURNAL OF INORGANIC BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now